encourcia 10 mg/10 mg hartkapseln
glaxosmithkline trading services limited - geschäftsanschrift - (8137796) - amlodipinbesilat; ramipril - hartkapsel - teil 1 - hartkapsel; amlodipinbesilat (24866) 13,87 milligramm; ramipril (22686) 10 milligramm
encourcia 5 mg/10 mg hartkapseln
glaxosmithkline trading services limited - geschäftsanschrift - (8137796) - amlodipinbesilat; ramipril - hartkapsel - teil 1 - hartkapsel; amlodipinbesilat (24866) 6,935 milligramm; ramipril (22686) 10 milligramm
nadroparin glaxosmithkline 9500 i.e. anti-xa/ml injektionslösung
glaxosmithkline gmbh & co. kg (8041694) - nadroparin-calcium ((mw: ca. 4300)) - injektionslösung - teil 1 - injektionslösung; nadroparin-calcium ((mw: ca. 4300)) (27569) 73 milligramm
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - split-influenza-virus, inaktiviert, enthält antigen: a / vietnam / 1194/2004 (h5n1) -ähnlicher stamm (nibrg-14) - influenza, human; immunization; disease outbreaks - impfstoffe - prophylaxe der influenza in einer offiziell erklärten pandemie-situation. pandemischer influenza-impfstoff sollte in Übereinstimmung mit offiziellen leitlinien verwendet werden.
benzocain 8 mg lutschpastillen
glaxosmithkline consumer healthcare gmbh & co. kg (8090037) - benzocain - lutschpastille - teil 1 - lutschpastille; benzocain (00023) 8 milligramm
relenza 5 mg/dose einzeldosiertes pulver zur inhalation
glaxosmithkline pharmaceuticals - zanamivir - einzeldosiertes pulver zur inhalation - 5 mg/dose - zanamivir 5 mg/dose - zanamivir
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastische mittel - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
jemperli
glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.
daraprim 25 mg tablette
glaxosmithkline pharmaceuticals - pyrimethamin - tablette - 25 mg - pyrimethamin 25 mg - pyrimethamine
betnelan v 0,1 % salbe
glaxosmithkline pharmaceuticals - betamethasone valerate - salbe - 0,1 % - betamethasone valerate 1.21 mg/g - betamethasone